Entecavir Alternatives Compared
| Entecavir | Baraclude (entecavir) | Tenofovir disoproxil |
|
|---|
| Entecavir | Baraclude (entecavir) | Tenofovir disoproxil |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Hepatitis B. Entecavir may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Hepatitis B. Baraclude may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Hepatitis B, HIV Infection, Nonoccupational Exposure, Occupational Exposure. Tenofovir disoproxil may also be used for purposes not listed in this medication guide. |
Related suggestions Hepatitis B
|
|||||||||||||||
| More about Entecavir | More about Baraclude (entecavir) | More about Tenofovir disoproxil | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Entecavir has an average rating of 10.0 out of 10 from a total of 3 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Baraclude has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Tenofovir disoproxil has an average rating of 8.2 out of 10 from a total of 25 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
Lower cost generic |
N/A |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Entecavir prices |
View all Baraclude prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||
|
|
N/A |
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Baraclude |
N/A |
Viread | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
149 hours |
149 hours |
180 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 156 drugs are known to interact with Entecavir:
|
A total of 156 drugs are known to interact with Baraclude:
|
A total of 236 drugs are known to interact with Tenofovir disoproxil:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
March 29, 2005 |
March 29, 2005 |
October 26, 2001 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.